RZH
PFE icon

Relyea Zuckerberg Hanson’s Pfizer PFE Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Sell
13,950
-1,896
-12% -$49.6K 0.03% 231
2026
Q1 		$445K Buy
15,846
+736
+5% +$19.6K 0.04% 172
2025
Q4 		$376K Buy
15,110
+2,598
+21% +$65.5K 0.04% 195
2025
Q3 		$319K Sell
12,512
-819
-6% -$20.2K 0.03% 208
2025
Q2 		$323K Buy
13,331
+3,825
+40% +$89.2K 0.04% 204
2025
Q1 		$241K Sell
9,506
-1,196
-11% -$31.3K 0.03% 233
2024
Q4 		$284K Sell
10,702
-4,548
-30% -$123K 0.04% 216
2024
Q3 		$441K Buy
15,250
+1,904
+14% +$55.5K 0.07% 149
2024
Q2 		$373K Buy
13,346
+2,204
+20% +$60.7K 0.06% 156
2024
Q1 		$309K Buy
11,142
+547
+5% +$15.2K 0.05% 177
2023
Q4 		$305K Sell
10,595
-3,320
-24% -$100K 0.06% 166
2023
Q3 		$462K Sell
13,915
-2,533
-15% -$89.6K 0.11% 113
2023
Q2 		$603K Buy
16,448
+4,680
+40% +$182K 0.14% 96
2023
Q1 		$480K Sell
11,768
-560
-5% -$24.2K 0.12% 107
2022
Q4 		$632K Buy
12,328
+3,376
+38% +$162K 0.18% 81
2022
Q3 		$392K Sell
8,952
-1,664
-16% -$80.9K 0.14% 99
2022
Q2 		$557K Buy
10,616
+525
+5% +$26.8K 0.21% 74
2022
Q1 		$536K Buy
10,091
+49
+0.5% +$2.54K 0.18% 89
2021
Q4 		$530K Buy
10,042
+1,196
+14% +$59.3K 0.19% 87
2021
Q3 		$380K Buy
8,846
+1,428
+19% +$63.3K 0.15% 98
2021
Q2 		$290K Buy
7,418
+468
+7% +$18.2K 0.12% 102
2021
Q1 		$267K Buy
6,950
+125
+2% +$4.44K 0.12% 106
2020
Q4 		$251K Sell
6,825
-448
-6% -$16.4K 0.13% 102
2020
Q3 		$252K Buy
7,273
+322
+5% +$11.3K 0.16% 97
2020
Q2 		$216K Sell
6,951
-499
-7% -$17K 0.17% 108
2020
Q1 		$231K Buy
7,450
+33
+0.4% +$1.12K 0.25% 92
2019
Q4 		$276K Buy
+7,417
New +$264K 0.27% 90

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Relyea Zuckerberg Hanson's PFE Position: Q2 2026 in Review

Relyea Zuckerberg Hanson reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $49.6K and leaving 13,950 shares worth $336K. The position accounts for 0.03% of the portfolio, ranked #231.

Relyea Zuckerberg Hanson first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $632K in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Relyea Zuckerberg Hanson held 13,950 shares of Pfizer worth $336K as of Q2 2026.
  • Relyea Zuckerberg Hanson sold 1,896 Pfizer shares in Q2 2026, an estimated $49.6K.
  • Pfizer made up 0.03% of Relyea Zuckerberg Hanson's portfolio in Q2 2026, its #231 holding.
  • Relyea Zuckerberg Hanson first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Relyea Zuckerberg Hanson's Pfizer position peaked at $632K in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.